vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and Bio-Techne (TECH). Click either name above to swap in a different company.
ALBANY INTERNATIONAL CORP is the larger business by last-quarter revenue ($321.2M vs $295.9M, roughly 1.1× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 4.3%, a 8.5% gap on every dollar of revenue. On growth, ALBANY INTERNATIONAL CORP posted the faster year-over-year revenue change (12.0% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 1.2%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
AIN vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $295.9M |
| Net Profit | $13.9M | $38.0M |
| Gross Margin | 31.1% | 64.6% |
| Operating Margin | 9.3% | 18.4% |
| Net Margin | 4.3% | 12.8% |
| Revenue YoY | 12.0% | -6.4% |
| Net Profit YoY | -21.5% | 68.3% |
| EPS (diluted) | $0.56 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $295.9M | ||
| Q3 25 | $261.4M | — | ||
| Q2 25 | $311.4M | $317.0M | ||
| Q1 25 | $288.8M | $316.2M | ||
| Q4 24 | $286.9M | $297.0M | ||
| Q3 24 | $298.4M | $289.5M | ||
| Q2 24 | $332.0M | $306.1M | ||
| Q1 24 | $313.3M | $303.4M |
| Q4 25 | $13.9M | $38.0M | ||
| Q3 25 | $-97.8M | — | ||
| Q2 25 | $9.2M | $-17.7M | ||
| Q1 25 | $17.4M | $22.6M | ||
| Q4 24 | $17.7M | $34.9M | ||
| Q3 24 | $18.0M | $33.6M | ||
| Q2 24 | $24.6M | $40.6M | ||
| Q1 24 | $27.3M | $49.1M |
| Q4 25 | 31.1% | 64.6% | ||
| Q3 25 | -19.1% | — | ||
| Q2 25 | 31.3% | 62.7% | ||
| Q1 25 | 33.4% | 67.9% | ||
| Q4 24 | 31.5% | 65.3% | ||
| Q3 24 | 30.3% | 63.2% | ||
| Q2 24 | 33.9% | 66.4% | ||
| Q1 24 | 34.7% | 67.4% |
| Q4 25 | 9.3% | 18.4% | ||
| Q3 25 | -44.6% | — | ||
| Q2 25 | 7.2% | -7.5% | ||
| Q1 25 | 9.8% | 12.2% | ||
| Q4 24 | 8.5% | 16.0% | ||
| Q3 24 | 8.4% | 13.8% | ||
| Q2 24 | 12.9% | 15.0% | ||
| Q1 24 | 12.4% | 22.1% |
| Q4 25 | 4.3% | 12.8% | ||
| Q3 25 | -37.4% | — | ||
| Q2 25 | 2.9% | -5.6% | ||
| Q1 25 | 6.0% | 7.1% | ||
| Q4 24 | 6.2% | 11.7% | ||
| Q3 24 | 6.0% | 11.6% | ||
| Q2 24 | 7.4% | 13.3% | ||
| Q1 24 | 8.7% | 16.2% |
| Q4 25 | $0.56 | $0.24 | ||
| Q3 25 | $-3.37 | — | ||
| Q2 25 | $0.31 | $-0.11 | ||
| Q1 25 | $0.56 | $0.14 | ||
| Q4 24 | $0.57 | $0.22 | ||
| Q3 24 | $0.57 | $0.21 | ||
| Q2 24 | $0.79 | $0.26 | ||
| Q1 24 | $0.87 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $172.9M |
| Total DebtLower is stronger | $455.7M | $260.0M |
| Stockholders' EquityBook value | $726.2M | $2.0B |
| Total Assets | $1.7B | $2.5B |
| Debt / EquityLower = less leverage | 0.63× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $172.9M | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $106.7M | $162.2M | ||
| Q1 25 | $119.4M | $140.7M | ||
| Q4 24 | $115.3M | $177.5M | ||
| Q3 24 | $127.2M | $187.5M | ||
| Q2 24 | $116.4M | $152.9M | ||
| Q1 24 | $125.4M | $145.3M |
| Q4 25 | $455.7M | $260.0M | ||
| Q3 25 | $480.6M | — | ||
| Q2 25 | $444.7M | $346.0M | ||
| Q1 25 | $416.4M | $330.0M | ||
| Q4 24 | $318.5M | $300.0M | ||
| Q3 24 | $362.2M | $300.0M | ||
| Q2 24 | $377.1M | $319.0M | ||
| Q1 24 | $439.1M | $389.0M |
| Q4 25 | $726.2M | $2.0B | ||
| Q3 25 | $739.3M | — | ||
| Q2 25 | $888.6M | $1.9B | ||
| Q1 25 | $900.0M | $2.0B | ||
| Q4 24 | $943.5M | $2.1B | ||
| Q3 24 | $991.0M | $2.1B | ||
| Q2 24 | $967.5M | $2.1B | ||
| Q1 24 | $967.5M | $2.0B |
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.7B | $2.6B | ||
| Q4 24 | $1.6B | $2.7B | ||
| Q3 24 | $1.8B | $2.7B | ||
| Q2 24 | $1.8B | $2.7B | ||
| Q1 24 | $1.8B | $2.7B |
| Q4 25 | 0.63× | 0.13× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.50× | 0.18× | ||
| Q1 25 | 0.46× | 0.16× | ||
| Q4 24 | 0.34× | 0.14× | ||
| Q3 24 | 0.37× | 0.14× | ||
| Q2 24 | 0.39× | 0.15× | ||
| Q1 24 | 0.45× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | — |
| Free Cash FlowOCF − Capex | $51.4M | — |
| FCF MarginFCF / Revenue | 16.0% | — |
| Capex IntensityCapex / Revenue | 6.9% | — |
| Cash ConversionOCF / Net Profit | 5.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $32.7M | $98.2M | ||
| Q1 25 | $2.1M | $41.1M | ||
| Q4 24 | $78.5M | $84.3M | ||
| Q3 24 | $47.0M | $63.9M | ||
| Q2 24 | $83.4M | $75.5M | ||
| Q1 24 | $9.6M | $81.0M |
| Q4 25 | $51.4M | — | ||
| Q3 25 | $25.9M | — | ||
| Q2 25 | $18.8M | $93.3M | ||
| Q1 25 | $-13.5M | $31.0M | ||
| Q4 24 | $60.2M | $77.5M | ||
| Q3 24 | $31.6M | $54.7M | ||
| Q2 24 | $63.6M | $57.5M | ||
| Q1 24 | $-17.3M | $64.5M |
| Q4 25 | 16.0% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | 6.0% | 29.4% | ||
| Q1 25 | -4.7% | 9.8% | ||
| Q4 24 | 21.0% | 26.1% | ||
| Q3 24 | 10.6% | 18.9% | ||
| Q2 24 | 19.2% | 18.8% | ||
| Q1 24 | -5.5% | 21.3% |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 4.5% | 1.5% | ||
| Q1 25 | 5.4% | 3.2% | ||
| Q4 24 | 6.4% | 2.3% | ||
| Q3 24 | 5.2% | 3.2% | ||
| Q2 24 | 6.0% | 5.9% | ||
| Q1 24 | 8.6% | 5.4% |
| Q4 25 | 5.31× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 0.12× | 1.82× | ||
| Q4 24 | 4.44× | 2.42× | ||
| Q3 24 | 2.61× | 1.90× | ||
| Q2 24 | 3.39× | 1.86× | ||
| Q1 24 | 0.35× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
